Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering.
Michels KR, Sheih A, Hernandez SA, Brandes AH, Parrilla D, Irwin B, Perez AM, Ting HA, Nicolai CJ, Gervascio T, Shin S, Pankau MD, Muhonen M, Freeman J, Gould S, Getto R, Larson RP, Ryu BY, Scharenberg AM, Sullivan AM, Green S.
Michels KR, et al. Among authors: ting ha.
J Immunother Cancer. 2023 Mar;11(3):e006292. doi: 10.1136/jitc-2022-006292.
J Immunother Cancer. 2023.
PMID: 36918221
Free PMC article.